Fresenius Medical Care Ag ADR (FMS) Stock Price, Quote & News

Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 49 6172 609 0

Website: www.freseniusmedicalcare.com

Address:

Else-Kröner-Strasse 1, Bad Homburg, Germany

Noname2022 May. 13 at 11:25 AM

$CRMD $AKBA $FMS $DVA https://www.govtrack.us/congress/bills/119/hr6214/cosponsors

0 · Reply

topstockalerts May. 12 at 9:34 PM

$FMS one minute it was flat, the next it started acting like a leader.

0 · Reply

Noname2022 May. 12 at 7:44 PM

$CRMD $AKBA $FMS $DVA

0 · Reply

Noname2022 May. 12 at 2:38 AM

$AKBA $CRMD $DVA $FMS

0 · Reply

Noname2022 May. 12 at 2:21 AM

$CRMD $FMS

1 · Reply

CapitalMonk May. 11 at 11:04 PM

$FMS Price: $21.76 (-1.23%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.57% RSI: 40.2 | Momentum: Moderate Volume: +3.1% vs avg Volatility: 2.99% Support: $20.02 | Resistance: $23.71 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

Noname2022 May. 10 at 3:23 PM

$DVA $FMS $CRMD https://www.investing.com/news/transcripts/earnings-call-transcript-fresenius-medical-care-q1-2026-beats-eps-expectations-93CH-4659185

2 · Reply

Noname2022 May. 8 at 2:21 AM

$DVA $FMS

0 · Reply

Noname2022 May. 7 at 10:12 PM

$CRMD $DVA $FMS

1 · Reply

OfficialStocktwitsUser May. 7 at 10:08 PM

$FMS RSI: 35.03, MACD: -0.3741 Vol: 0.84, MA20: 22.60, MA50: 22.68 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Fresenius Medical price target lowered to EUR 40 from EUR 42 at Deutsche Bank

2026-05-07T02:38:13.000Z - 6 days ago

Fresenius Medical price target lowered to EUR 33 from EUR 34 at Morgan Stanley

2026-05-06T16:03:38.000Z - 6 days ago

Q1 2026 Fresenius Medical Care AG Earnings Call Transcript

2026-05-05T20:50:04.000Z - 7 days ago

Relative Strength Alert For Fresenius Medical Care

2026-05-05T15:16:23.000Z - 7 days ago

EQS-CMS: Fresenius Medical Care AG : Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

May 5, 2026, 8:00 AM EDT - 8 days ago

Fresenius Medical Care AG Earnings Call Transcript: Q1 2026

2026-05-05T11:50:11.000Z - 8 days ago

Fresenius Medical reports Q1 EPS ex-items EUR0.91 vs. EUR0.84 last year

2026-05-05T11:49:09.000Z - 8 days ago

Fresenius Medical sees FY26 revenue EUR19.628B

May 5, 2026, 7:00 AM EDT - 8 days ago

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

FMS

2026-05-05T11:00:00.000Z - 8 days ago

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

2026-05-05T10:58:01.000Z - 8 days ago

Palantir stark, ON Semi solide, Nebius im Höhenflug

May 5, 2026, 3:22 AM EDT - 8 days ago

Fresenius Medical Care Posts Lower Net Profit on One-Off Costs

FMS

May 5, 2026, 1:08 AM EDT - 8 days ago

Fresenius Medical Care's revenue falls in Q1 as weak dollar takes toll

FMS

2026-04-24T16:35:55.000Z - 18 days ago

Fresenius Medical price target raised to EUR 40 from EUR 39.50 at Citi

2026-04-24T12:33:04.000Z - 19 days ago

Humacyte realigns ex-U.S. rights to Symvess through Fresenius Medical pact

HUMA

2026-04-24T12:00:00.000Z - 19 days ago

Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess

2026-04-21T13:33:40.000Z - 21 days ago

Quest Diagnostics Q1 2026 Earnings Call: Complete Transcript

2026-04-20T09:52:53.000Z - 23 days ago

EQS-CMS: Fresenius Medical Care AG : Release of a capital market information

2026-03-02T19:55:29.000Z - 2 months ago

Fresenius Medical price target lowered to EUR 42 from EUR 44 at Deutsche Bank

2026-02-26T18:25:55.000Z - 2 months ago

Fresenius Medical price target lowered to EUR 34 from EUR 36 at Morgan Stanley

Feb 24, 2026, 8:00 AM EST - 2 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q4 2025

2026-02-24T12:11:35.000Z - 2 months ago

Fresenius Medical reports Q4 EPS ex-items EUR1.44 vs. EUR0.91 last year

Feb 24, 2026, 7:00 AM EST - 2 months ago

Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band

FMS

Feb 24, 2026, 6:42 AM EST - 2 months ago

Fresenius Medical Care Shares Drop After Outlook, U.S. Performance Underwhelms

FMS

Feb 24, 2026, 4:00 AM EST - 2 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q4 2025

Feb 24, 2026, 1:08 AM EST - 2 months ago

Fresenius Medical Care's operating profit surges in Q4

FMS

2026-01-27T16:30:41.000Z - 3 months ago

Fresenius Medical price target lowered to EUR 36 from EUR 37 at Morgan Stanley

2026-01-26T17:20:13.000Z - 3 months ago

Fresenius Medical price target lowered to EUR 44 from EUR 46 at Deutsche Bank

2026-01-23T18:40:30.000Z - 3 months ago

Fresenius Medical price target lowered to EUR 39.50 from EUR 48.50 at Citi

2026-01-20T09:25:08.000Z - 4 months ago

Fresenius Medical downgraded to Neutral from Buy at Goldman Sachs

Jan 13, 2026, 2:15 PM EST - 4 months ago

Fresenius Medical Care AG Transcript: 44th Annual J.P. Morgan Healthcare Conference

2026-01-09T12:06:22.000Z - 4 months ago

Fresenius Medical to accelerate its share buyback program

Jan 9, 2026, 7:00 AM EST - 4 months ago

Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned

FMS

2026-01-05T12:20:32.000Z - 4 months ago

Fresenius Medical price target raised to $28 from $26 at Truist

2025-12-15T16:55:44.000Z - 5 months ago

Fresenius Medical price target lowered to EUR 37 from EUR 39 at Morgan Stanley

2025-12-10T13:11:15.000Z - 5 months ago

Fresenius Medical names Charles Hugh-Jones as Global Chief Medical Officer

Dec 10, 2025, 8:00 AM EST - 5 months ago

Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board

FMS

2025-12-08T17:21:09.000Z - 5 months ago

Fresenius Medical price target lowered to EUR 37.40 from EUR 41.50 at JPMorgan

2025-11-10T18:40:45.000Z - 6 months ago

Fresenius Medical price target lowered to EUR 39 from EUR 41 at Morgan Stanley

Nov 4, 2025, 8:00 AM EST - 6 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q3 2025

Nov 4, 2025, 7:00 AM EST - 6 months ago

Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025

FMS

Nov 4, 2025, 1:08 AM EST - 6 months ago

Fresenius Medical Care beats quarterly profit estimates helped by cost cuts

FMS

Oct 30, 2025, 9:00 AM EDT - 6 months ago

Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025

FMS

Oct 1, 2025, 9:35 AM EDT - 7 months ago

Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement

FMS

Sep 18, 2025, 3:30 PM EDT - 8 months ago

Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment

FMS

Aug 11, 2025, 7:00 AM EDT - 9 months ago

Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework

FMS

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q2 2025

Aug 5, 2025, 7:00 AM EDT - 10 months ago

Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025

FMS

Jul 18, 2025, 4:25 AM EDT - 10 months ago

$6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical

FMS

Jul 3, 2025, 8:00 AM EDT - 11 months ago

Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

FMS

Jun 17, 2025, 8:56 AM EDT - 11 months ago

Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs

Jun 17, 2025, 7:00 AM EDT - 11 months ago

Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation

Jun 17, 2025, 4:08 AM EDT - 11 months ago

Fresenius Medical Care announces 1 bln euros share buyback programme

Jun 4, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.

May 30, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025

May 22, 2025, 11:45 AM EDT - 1 year ago

Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History

May 6, 2025, 7:00 AM EDT - 1 year ago

Fresenius Medical Care starts 2025 with strong organic revenue and income growth

May 6, 2025, 1:04 AM EDT - 1 year ago

Fresenius Medical Care tops market expectations in 1st quarter

Apr 9, 2025, 6:32 PM EDT - 1 year ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Mar 13, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum

Mar 4, 2025, 3:57 AM EST - 1 year ago

Fresenius Medical Care's stock falls on Fresenius' stake sale

Feb 25, 2025, 7:00 AM EST - 1 year ago

Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025

Feb 25, 2025, 1:14 AM EST - 1 year ago

Fresenius Medical Care slightly beats market estimates in fourth quarter

Feb 24, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

DGX

Dec 23, 2024, 9:00 AM EST - 1 year ago

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Dec 20, 2024, 11:23 AM EST - 1 year ago

Fresenius Medical Care returns to Dax 40 Index

Nov 5, 2024, 8:33 PM EST - 1 year ago

Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO

Nov 5, 2024, 7:00 AM EST - 1 year ago

Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024

Oct 21, 2024, 11:04 AM EDT - 1 year ago

Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Jul 30, 2024, 9:30 PM EDT - 1 year ago

Fresenius Medical Care CEO says strategy is working as company delivers on transformation efforts

Jul 30, 2024, 7:00 AM EDT - 1 year ago

Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

Jul 13, 2024, 9:16 AM EDT - 1 year ago

US FTC probing DaVita, Fresenius Medical, Politico reports

DVA

Jun 12, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations

May 23, 2024, 12:33 PM EDT - 2 years ago

Moody's and S&P change Fresenius Medical Care's rating outlook to stable

May 21, 2024, 10:00 AM EDT - 2 years ago

Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024

May 16, 2024, 9:55 AM EDT - 2 years ago

Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets

May 11, 2024, 6:42 AM EDT - 2 years ago

Fresenius Medical sees up to 2% US dialysis growth by year-end

May 7, 2024, 10:30 AM EDT - 2 years ago

We have positive momentum in operating performance: Fresenius Medical Care CEO

May 7, 2024, 7:00 AM EDT - 2 years ago

Fresenius Medical Care starts the year with strong earnings growth

May 7, 2024, 4:08 AM EDT - 2 years ago

Fresenius Medical beats earnings expectations, keeps outlook; shares sink

Mar 22, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care

Mar 19, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device

Noname2022 May. 13 at 11:25 AM

$CRMD $AKBA $FMS $DVA https://www.govtrack.us/congress/bills/119/hr6214/cosponsors

0 · Reply

topstockalerts May. 12 at 9:34 PM

$FMS one minute it was flat, the next it started acting like a leader.

0 · Reply

Noname2022 May. 12 at 7:44 PM

$CRMD $AKBA $FMS $DVA

0 · Reply

Noname2022 May. 12 at 2:38 AM

$AKBA $CRMD $DVA $FMS

0 · Reply

Noname2022 May. 12 at 2:21 AM

$CRMD $FMS

1 · Reply

CapitalMonk May. 11 at 11:04 PM

0 · Reply

Noname2022 May. 10 at 3:23 PM

$DVA $FMS $CRMD https://www.investing.com/news/transcripts/earnings-call-transcript-fresenius-medical-care-q1-2026-beats-eps-expectations-93CH-4659185

2 · Reply

Noname2022 May. 8 at 2:21 AM

$DVA $FMS

0 · Reply

Noname2022 May. 7 at 10:12 PM

$CRMD $DVA $FMS

1 · Reply

OfficialStocktwitsUser May. 7 at 10:08 PM

0 · Reply

Noname2022 May. 7 at 5:56 PM

$AKBA $CRMD $DVA $FMS K-CAPA lobbying…

1 · Reply

wolverine May. 7 at 3:19 PM

$CRMD the way we are always pinned to a price every day make it feel like the big boys are always constantly in control. That’s fine know what you own, 95% of eligible $FMS patients now use DefenCath so that’s a huge uptake in such a short time!! $40 pice target here

1 · Reply

The_Gambl3r May. 7 at 3:09 AM

$LIVN $MDT $FMS $BAX $NUWE ** 👀👀

1 · Reply

Noname2022 May. 7 at 12:36 AM

$CRMD $FMS UBS analyst asked Defencath question on FMC Q1 call also appear to be a substantial CRMD holder.. “Graham, Analyst, UBS: Maybe just a quick follow-up on DefenCath. Are you guys seeing the benefits fairly quickly? It seems like something you might see a little bit of a tailwind relatively quickly from. Helen Giza, Chief Executive Officer and Chair of the Management Board, Fresenius Medical Care: For which, Graham? Did you say HDF? Graham, Analyst, UBS: for DefenCath. Helen Giza, Chief Executive Officer and Chair of the Management Board, Fresenius Medical Care: DefenCath. Graham, Analyst, UBS: catheter, products. Helen Giza, Chief Executive Officer and Chair of the Management Board, Fresenius Medical Care: Yes, for sure. With having more than 90% of our patients on that, we are really starting to see, you know, a real improvement and reduction in bloodstream-related infections.”

2 · Reply

Noname2022 May. 6 at 8:06 PM

$CRMD $AKBA $DVA $FMS

1 · Reply

Gencooliveoil May. 6 at 11:28 AM

$FMS $CRMD

0 · Reply

Gencooliveoil May. 6 at 11:27 AM

$CRMD $FMS

0 · Reply

Gencooliveoil May. 6 at 11:27 AM

$CRMD $FMS

0 · Reply

Estimize May. 6 at 10:00 AM

Wall St is expecting 0.63 EPS for $FMS Q2 [Reporting 08/04 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont

0 · Reply

Noname2022 May. 5 at 3:42 PM

$CRMD $FMS https://m.investing.com/news/transcripts/earnings-call-transcript-fresenius-medical-care-q1-2026-beats-eps-expectations-93CH-4659185?ampMode=1

1 · Reply

Noname2022 May. 5 at 3:41 PM

$CRMD $FMS

0 · Reply

Noname2022 May. 5 at 2:59 PM

$FMS $CRMD FMC Q1 call transcript https://m.investing.com/news/transcripts/earnings-call-transcript-fresenius-medical-care-q1-2026-beats-eps-expectations-93CH-4659185?ampMode=1

0 · Reply

Market Cap	12.15B
Revenue (ttm)	22.21B
Net Income (ttm)	1.11B
EPS (ttm)	N/A
PE Ratio	8.74
Forward PE	9.37
Profit Margin	4.98%
Debt to Equity Ratio	0.53

Volume	829,000
Avg Vol	626,524
Day's Range	N/A - N/A
Shares Out	558.58M
Stochastic %K	79%
Beta	0.81
Analysts	Hold
Price Target	$24.48